A Commitment to Excellence

About Merz

Merz North America is a specialty healthcare company that develops and commercializes innovative treatment solutions in aesthetics, dermatology and neurosciences in the U.S. and Canada.  Our ambition is to become a recognized leader in the treatment of movement disorders, and in aesthetics and dermatology. Our future is promising, and we are committed to advancing new therapeutic options and improving patients’ lives.

For more than 100 years, the development of our products has been based on Merz`s commitment to providing innovative medical approaches that earn trust of patients, physicians and partners worldwide. Globally, the companies of Merz Pharma Group are focused on medications for treating neurological and psychiatric illnesses, and they have assumed a leading role in the field of Alzheimer’s disease research.  Founded in 1908, Merz Pharma Group is a privately owned company headquartered in Frankfurt, Germany.

Meet our North America Leadership Team

Bob Rhatigan
President and CEO

Patrick Urban
Chief Commercial Officer

John Donofrio
Chief Financial Officer
Head – North American
Business Development

Bill Edwards, JD
Vice President
General Counsel

Salisa Hauptmann
Vice President
Chief Compliance Officer

Matt Anderson
Vice President
Technical Operations

Bob Bennett
President and General
Manager
Merz Pharma Canada, Ltd.

Glenn Block
Vice President
Head - North American
Neurosciences

Hyunna Coelho
Vice President
CORE Services

David Dobrowski
Vice President
North American Research
and Development

Jim Hartman
Vice President
Aesthetics and OTC Marketing

Jon Parrish
Vice President
Integrated Planning and Customer Experience

Denise Zomorrodian
Vice President
Managed Markets

Denise Zomorrodian
Vice President
Managed Markets

Denise is responsible for leading the MNA Managed Markets team. She will have responsibility for the Field Reimbursement Team, the National Accounts Team, and the Federal Accounts Team. Denise has been with Merz for three years and prior to this role served as the Senior Director of Managed Markets. She has held progressive leadership roles within field sales, contracting, pricing & strategy, commercial analytics and managed markets. Denise has a proven track record of success in working with payers to influence category management for specialty biologics governed under the medical benefit. She has also built a team of National Account Directors who have successfully engaged key decision makers across payer channels to secure optimal access for our portfolio of products including coverage and reimbursement consistent with FDA labeling, gaining broader traction of our Xeomin preference strategy and expanding channel strategies to develop business for the neuroscience team. Prior to joining Merz, she spent 17 years with Johnson & Johnson.

Bob Rhatigan
President and CEO

Mr. Rhatigan is the President and CEO of Merz North America. In this capacity, he is responsible for leading the company strategy and operations across the United States and Canada.

Mr. Rhatigan holds a proven track record of success in driving business, building strong teams and developing leading brands in the medical aesthetics arena. Prior to joining Merz, Mr. Rhatigan spent 17 years at Allergan where he completed his tenure as Senior Vice President, General Manager and Chief Executive of SkinMedica®. Before this role, Mr. Rhatigan served as Senior Vice President of Allergan’s Facial Aesthetic business, where he led the launches and marketplace success of BOTOX® Cosmetic, JUVÉDERM® and LATISSE® in the United States.

In addition to his experience in Facial Aesthetics, Mr. Rhatigan has extensive leadership and product launch experience across Neurosciences, Medical Dermatology and Eye Care.

Prior to Allergan, Mr. Rhatigan spent nine years at Procter and Gamble in a variety of roles of increasing responsibility in sales and marketing. Mr. Rhatigan most recently served as President and Chief Operating Officer at Alphaeon, a medical aesthetics start-up company.

Mr. Rhatigan is a member of the Merz’s global management board in addition to the US Boards.

Jon Parrish
Vice President
Integrated Planning and Customer Experience

David Dobrowski
Vice President
North American Research
and Development

David joined Merz in March 2011 and currently serves as Vice President and Head of North American Research and Development. In this role, he is responsible for all medical, regulatory and product safety functions for Merz in North America. He leads the planning and execution of all clinical and pre-clinical development programs in North America and serves as the Global lead on all of Merz‘s research and development activities relating to medical dermatology. He brings more than 23 years of experience in the pharmaceutical and medical device space and holds a Bachelor of Science degree from University of North Carolina at Wilmington. David is a member of the Regulatory Affairs Professional Society (RAPS), Drug Information Association (DIA) and the North Carolina Regulatory Affairs Forum (NCRAF).

Patrick Urban
Chief Commercial Officer

Patrick Urban is the Chief Commercial Officer and plays a critical role in driving the commercial success of the Merz Aesthetics portfolio. He oversees all aesthetics customer facing points of contact to integrate and enhance the customer experience. In particular, he leads the US aesthetics sales force, the integrated planning and customer solutions team, inside sales and support as well as the managed markets team.

Mr. Urban brings more than 20 years of commercial experience in the U.S. pharmaceutical and medical device industries. He has served in various leadership roles to include the Vice-President of US Aesthetics Sales and the Vice-President of Sales and Marketing for the Ulthera Business Unit.

Patrick holds a Bachelor‘s degree in Marketing from Bloomsburg University in Pennsylvania and earned his MBA at Loyola College in Baltimore, Maryland. He is based in Merz’s North American headquarters in Raleigh, North Carolina.

Salisa Hauptmann
Vice President
Chief Compliance Officer

Salisa joined Merz in March 2015 as Vice President and Chief Compliance Officer. In this role, she is responsible for providing strategic and operational leadership to Merz on matters relating to compliance issues, including industry standards established by the Department of Health and Human Services, the Office of Inspector General, and other Federal and state agencies. Prior to joining Merz, Salisa served as Vice President, Global Regulatory Affairs – Emerging Markets, Asia Pacific and Europe for GlaxoSmithKline. She brings more than 20 years of pharmaceutical regulatory and compliance experience to her current role. Her career includes time spent at Stiefel Laboratories and Novartis, and she has a breadth of experience across multiple specialties, including dermatology, neurology, oncology and respiratory disorders. Hauptmann holds a Bachelor of Science degree from University of California, Davis; she earned her Master of Public Health degree at Webster University in St. Louis, Missouri.

Matt Anderson
Vice President
Technical Operations

Matt joined Merz in August 2011 as Vice President, Quality Operations & Business Excellence and currently serves as Vice President – Technical Operations. In this role, he is primarily accountable for manufacturing operations, supply chain management for Merz in the U.S. and quality operations globally. Prior to joining Merz, he served as Corporate Quality Director and Management Representative for Baxter’s Global Purchasing and Supply Chain organizations. Matt has more than 20 years of experience within the biomedical, pharmaceutical and medical device industries. He has been certified as a Quality Engineer, Six Sigma Green Belt, and as an ISO Lead Auditor for Medical Devices. Matt holds a Bachelor of Science degree in Molecular Biology and Pre-Health from the University of Wisconsin Parkside and studied Total Quality Management at the graduate level at Marquette University.

John Donofrio
Chief Financial Officer
Head – North American
Business Development

Bob Bennett
President and General
Manager
Merz Pharma Canada, Ltd.

Bob Bennett currently serves as President and General Manager – Merz Pharma Canada, Ltd. Bob joined Merz in September 2008 as Director of Marketing and Sales, Canada, and most recently served as Business Unit Director – Aesthetics/OTC. He brings more than 25 years of pharmaceutical sales and marketing experience to his role as head of Merz’s Canadian business. Bob holds a Bachelor’s degree in Economics from Wilfrid Laurier University.

Jim Hartman
Vice President
Aesthetics and OTC Marketing

Jim Hartman currently serves as Vice President and US Head of Marketing for Aesthetics & OTC. In this role, Jim leads the strategic development, marketing and commercial implementation for the Aesthetics & OTC portfolio including device, injectables and skincare.  His role acts as a leading conduit between the commercial strategy and needs for success in the US and our Global Project Teams for aesthetics. He has more than 24 years of experience in the pharmaceutical industry, with more than 15 of those years focused on the development and marketing of specialty pharmaceutical products. Jim holds a Bachelor of Arts degree in Social Science from the University of California, Irvine. He is based in Merz’s North American headquarters in Raleigh, North Carolina.

Bill Edwards, JD
Vice President
General Counsel

Bill joined Merz in March 2009 as Vice President & General Counsel. In October of 2012, Bill was selected to lead the Company’s legal function in the US. In addition, Bill continues to serve as General Counsel, Vice President, and Secretary of the parent/holding company of Merz Pharmaceuticals, LLC, and Merz Aesthetics, Inc. Bill has over 23 years of experience providing legal counsel to pharmaceutical companies and to diverse components of the US healthcare delivery system. Bill holds his Juris Doctor and Master of Social Work from the University of North Carolina at Chapel Hill, where he was an editor of the North Carolina Law Review. He received a Bachelor or Arts degree from the University of Virginia. Bill is a member of the North Carolina Bar.

Hyunna Coelho
Vice President
CORE Services

Hyunna joined Merz in November 2009 and currently serves as Vice President of CORE Services. As part of CORE Services, Hyunna leads: Corporate Communications; Commercial Analytics; Operations; Industry and Convention Services; Human Resources; Training and Development; Organizational Development; and Production, Media & Events. She has more than 27 years of experience in the healthcare industry, with more than 14 of those years focused on sales training and development and commercial operations in specialty pharmaceuticals. Hyunna holds a Master of Business Administration in Pharmaceutical Marketing from St. Joseph’s University in Philadelphia, Pennsylvania. She obtained her Bachelor of Science degree from the University of South Carolina.

Glenn Block
Vice President
Head - North American
Neurosciences

Glenn joined Merz in August 2007 and currently serves as Vice President and Head – U.S. Neurosciences. Prior to this, Glenn held the role of President and General Manager of Merz Pharma Canada Ltd. and holds the distinction of having built Merz’s Canadian organization from the ground up. Glenn has over 20 years of experience in the pharmaceutical industry, with most of those years focused on the development and marketing of neurotoxins in North America. Glenn holds an Honors Bachelor of Commerce degree from Queen’s University in Kingston, Ontario.